Hepatitis C Infection clinical trials
32 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV
- Implementing Low-Barrier HCV Treatment in a Jail Setting
- California MEPS Hub
- Appalachian Partnership to Reduce Disparities (Aim 2)
- Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
- Feasibility and Acceptability of HCV Treatment in Pregnancy
- The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
- Rapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine Clinic
- Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
- Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Comparison of ALD, NASH, and Healthy Control Patients
- Blood Collection Biorepository for Liver Disease Research
- The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
- Evaluation of Patients With Liver Disease
- Hepatitis C Pharmacist, Physician, Patient Navigator Collaborative Care Model in Permanent Supportive Housing
- Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
- Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
- Persuasive Health Communication Intervention for HIV/HCV
- Hepatitis C Tracker Study
- A Setting Focus Overdose Prevention Intervention
- Project I Test: Implementing HIV Testing in Opioid Treatment Programs
- Fibrinogen in Liver Transplant
- HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking
- Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
- Pilot Study of an Adapted Partner Navigation Intervention Booster Session for Sustained Healthcare Engagement Among People Who Inject Drugs
- Assessing Performance of a Hepatitis C Emergency Department (HepC-EnD) Screening Tool: IT Integration Process for Electronic Health Record System
- ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing
- Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Pilot Testing: Aim3)
- HIV/HBV/HCV Triple Screening in Primary Care
- Comparative Autoantibody and Immunologic Cell Marker Study
- DBS TaT in Peer-assisted Telemedicine for Hepatitis C
- The HOPE Study: Characterizing Patients With Hepatitis B and C
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Hepatitis C Infection” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.